PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
4.750
+0.180 (3.94%)
At close: Jun 26, 2026, 4:00 PM EDT
4.920
+0.170 (3.58%)
After-hours: Jun 26, 2026, 7:14 PM EDT
PolyPid Employees
As of December 31, 2025, PolyPid had 75 total employees, including 69 full-time and 6 part-time employees. The number of employees increased by 14 or 22.95% compared to the previous year.
Employees
75
Change (1Y)
14
Growth (1Y)
22.95%
Revenue / Employee
n/a
Profits / Employee
-$448,387
Market Cap
91.08M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Seer, Inc. | 124 |
| Inovio Pharmaceuticals | 112 |
| Adicet Bio | 102 |
| Fortress Biotech | 78 |
| ImmuCell | 73 |
| Rani Therapeutics Holdings | 71 |
| NeurAxis | 24 |
PYPD News
- 26 days ago - PolyPid completes NDA submission to FDA for D-PLEX100 - TheFly
- 26 days ago - PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀ - GlobeNewsWire
- 4 weeks ago - PolyPid Transcript: Lytham Partners Spring 2026 Investor Conference - Transcripts
- 5 weeks ago - PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference - GlobeNewsWire
- 6 weeks ago - PolyPid reports Q1 EPS (35c), consensus (43c) - TheFly
- 6 weeks ago - PolyPid Earnings Call Transcript: Q1 2026 - Transcripts
- 6 weeks ago - PolyPid Earnings release: Q1 2026 - Filings
- 6 weeks ago - PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results - GlobeNewsWire